ResMedRMDEarnings & Financial Report
ResMed Inc. is a medical equipment company based in San Diego, California, and founded in Australia. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea, chronic obstructive pulmonary disease (COPD), and other respiratory conditions. Resmed produced hundreds of thousands of ventilators and bilevel devices to help treat the respiratory symptoms of patients with COVID-19.
Revenue
$1.3B
Gross Profit
$766.4M
Operating Profit
$426.3M
Net Profit
$365.0M
Gross Margin
59.3%
Operating Margin
33.0%
Net Margin
28.3%
YoY Growth
7.9%
EPS
$2.48
ResMed Q3 FY2025 Financial Summary
ResMed reported revenue of $1.3B (up 7.9% YoY) for Q3 FY2025, with a net profit of $365.0M (up 21.5% YoY) (28.3% margin). Cost of goods sold was $525.3M, operating expenses totaled $340.1M.
Key Financial Metrics
| Total Revenue | $1.3B |
|---|---|
| Net Profit | $365.0M |
| Gross Margin | 59.3% |
| Operating Margin | 33.0% |
| Report Period | Q3 FY2025 |
Revenue Breakdown
ResMed Q3 FY2025 revenue of $1.3B breaks down across 2 segments, led by Sleep And Breathing Health at $1.1B (87.5% of total).
| Segment | Revenue | % of Total |
|---|---|---|
| Sleep And Breathing Health | $1.1B | 87.5% |
| Residential Care Software | $161.2M | 12.5% |
ResMed Revenue by Segment — Quarterly Trend
ResMed revenue by segment across the last 4 reported quarters, showing how each business line (such as Sleep And Breathing Health and Residential Care Software) has evolved quarter over quarter.
| Segment | Q4 FY2026 | Q3 FY2026 | Q2 FY2026 | Q1 FY2026 |
|---|---|---|---|---|
| Sleep And Breathing Health | — | — | $1.3B | $1.2B |
| Residential Care Software | — | — | $166.9M | $166.1M |
ResMed Annual Revenue by Year
ResMed annual revenue history includes year-by-year totals (for example, 2026 revenue was $5.6B).
| Year | Annual Revenue |
|---|---|
| 2026 | $5.6B |
| 2025 | $5.1B |
| 2024 | $4.7B |
| 2023 | $4.2B |
| 2022 | $3.6B |
ResMed Quarterly Revenue & Net Profit History
ResMed results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q4 FY2026 | $1.4B | +11.0% | $392.6M | 27.6% |
| Q3 FY2026 | $1.4B | +10.8% | $398.7M | 27.9% |
| Q2 FY2026 | $1.4B | +11.0% | $392.6M | 27.6% |
| Q1 FY2026 | $1.3B | +9.1% | $348.5M | 26.1% |
| Q4 FY2025 | $1.3B | +10.2% | $379.7M | 28.2% |
| Q3 FY2025 | $1.3B | +7.9% | $365.0M | 28.3% |
| Q2 FY2025 | $1.3B | +10.3% | $344.6M | 26.9% |
| Q1 FY2025 | $1.2B | +11.1% | $311.4M | 25.4% |
Income Statement
| Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | Q3 2026 | Q4 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.22B | $1.28B | $1.29B | $1.35B | $1.34B | $1.42B | $1.43B | $1.42B |
| YoY Growth | 11.1% | 10.3% | 7.9% | 10.2% | 9.1% | 11.0% | 10.8% | 11.0% |
Balance Sheet
| Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | Q3 2026 | Q4 2026 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $7.22B | $7.14B | $7.57B | $8.17B | $8.31B | $8.50B | $8.78B | $8.50B |
| Liabilities | $2.03B | $1.89B | $2.02B | $2.21B | $2.19B | $2.18B | $2.29B | $2.18B |
| Equity | $5.20B | $5.25B | $5.55B | $5.97B | $6.12B | $6.32B | $6.49B | $6.32B |
Cash Flow
| Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|
| Operating CF | $325.5M | $308.6M | $578.7M | $538.8M | $457.3M | $339.7M |